Gamma-synuclein and the progression of cancer
- PMID: 17567567
- DOI: 10.1096/fj.07-8379rev
Gamma-synuclein and the progression of cancer
Abstract
The synucleins are a small, soluble, highly conserved group of neuronal proteins that have been implicated in both neurodegenerative diseases and cancer. The synuclein family consists of alpha-, beta-, and gamma-synucleins (gamma-syn). They are a natively unfolded group of proteins that share sequence homologies and structural properties. So far, the biological functions of the synucleins are still unclear, but their involvement in neurodegenerative diseases and cancer may provide insights into the pathological processes that result from these two groups of debilitating diseases, and present the possibility to use them as potential targets for early diagnosis and treatment. Recently, elevated levels of gamma-syn proteins have been detected in various types of cancer, especially in advanced stages of the disease. Furthermore, studies to date indicate that overexpression of gamma-syn compromises normal mitotic checkpoint controls, resulting in multinucleation as well as faster cell growth. Gamma-syn has also been shown to promote invasion and metastasis in in vitro assays as well as in animal models. Overexpression of gamma-syn also interferes with drug-induced apoptotic responses. These observations raise questions about the involvement of gamma-syn in the process of tumorigenesis and metastasis, and efforts have already been made to use gamma-syn as a marker for assessing breast cancer progression. This review will discuss the involvement of gamma-syn in cancer progression, metastasis and its potential as a marker.
Similar articles
-
Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.Oncol Rep. 2010 Feb;23(2):429-36. Oncol Rep. 2010. PMID: 20043104
-
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.Breast Cancer Res Treat. 2007 Mar;101(3):259-67. doi: 10.1007/s10549-006-9296-7. Epub 2006 Jul 4. Breast Cancer Res Treat. 2007. PMID: 16821081
-
Gamma synuclein: subcellular localization in neuronal and non-neuronal cells and effect on signal transduction.Cell Motil Cytoskeleton. 2001 Aug;49(4):218-28. doi: 10.1002/cm.1035. Cell Motil Cytoskeleton. 2001. PMID: 11746666
-
Synucleins: are they two-edged swords?J Neurosci Res. 2013 Feb;91(2):161-6. doi: 10.1002/jnr.23149. Epub 2012 Nov 14. J Neurosci Res. 2013. PMID: 23150342 Review.
-
Molecular and cellular biology of synucleins.Int Rev Cell Mol Biol. 2008;270:225-317. doi: 10.1016/S1937-6448(08)01406-8. Int Rev Cell Mol Biol. 2008. PMID: 19081538 Review.
Cited by
-
Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth.Sci Rep. 2021 Mar 4;11(1):5267. doi: 10.1038/s41598-021-84443-y. Sci Rep. 2021. PMID: 33664298 Free PMC article.
-
Navigating the Neurobiology of Parkinson's: The Impact and Potential of α-Synuclein.Biomedicines. 2024 Sep 18;12(9):2121. doi: 10.3390/biomedicines12092121. Biomedicines. 2024. PMID: 39335634 Free PMC article. Review.
-
Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules.Biomolecules. 2020 Oct 21;10(10):1465. doi: 10.3390/biom10101465. Biomolecules. 2020. PMID: 33096655 Free PMC article. Review.
-
Expression of gamma-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116.World J Gastroenterol. 2009 Oct 28;15(40):5035-43. doi: 10.3748/wjg.15.5035. World J Gastroenterol. 2009. PMID: 19859996 Free PMC article.
-
Mass spectrometry imaging in gynecological cancers: the best is yet to come.Cancer Cell Int. 2022 Dec 19;22(1):414. doi: 10.1186/s12935-022-02832-3. Cancer Cell Int. 2022. PMID: 36536419 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous